Fundamental Analysis
43 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +47.6% | -80.1% | 2 / 3 | +3.8% | +1.58 pp | +0.59 pp | +4.1% | 1.36 | 22.09 | 1.148 | +3,8% | 22,9 | +47,6% | 22.09 | 25.66 | −13,9% |
| Pts | 8 | 0 | 8 | 0 | 8 | 8 | 0 | 6 | 8 | |||||||
Valuation annotation:Price: 12.050 (close price on 2026-10-19)EPS (TTM): 545,6
Financial charts
1.Revenue & growth
VND bn1.148Q2/26
1.Revenue & growth
VND bn1.148Q2/26
2.Profit & growth
VND bn22,9Q2/26
3.Profit mix (Penman)
VND bn77,6Q2/26
4.Margins & cost structure
%13.6%Q2/26
5.Returns & cash cycle
% · days4.4%Q2/26
6.Earnings quality & cash
VND bn-40,6Q2/26
7.Asset structure
VND bn3.761Q2/26
8.Funding & debt health
VND bn · times3.761Q2/26
9.Revenue backlog
VND bn32,2Q2/26
10.Valuation
times · %22,1×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %221Q2/26
Adjusted EPS growth, latest quarter
47.6%
Average adjusted EPS growth, 3 quarters
-80.1%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26